Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- CNRS
- Nature Careers
- Inria, the French national research institute for the digital sciences
- Centre de Mise en Forme des Matériaux (CEMEF)
- Institut Pasteur
- Institut de chimie des milieux et matériaux de Poitiers - Equipe SAMCat
- Research Institute for Environmental and Occupational Health (IRSET - UMR_S INSERM 1085)
- University of Reims Champagne-Ardenne (URCA)
-
Field
-
. Among them, pore-forming proteins represent a unique class of biomolecules with the potential to be re-engineered into highly selective tools for targeting disease-relevant cells. This interdisciplinary
-
uses a tumor-targeting biomolecule (e.g. antibody, peptide, small molecule) labelled with a radionuclide for either diagnostic or therapeutic purposes. Alpha-particle targeted radionuclide therapy (-TRT
-
, engineering, bioinformatics, machine learning, artificial intelligence) to support minimally invasive and targeted preventive and predictive medicine capable of limiting age-related functional disorders
-
inflammation and immune response and PK dysregulation is well documented in inflammatory pathologies [8-13]. Moreover, several PKs constitute attractive pharmacological targets for therapeutic purposes, as
-
English. The candidate will have access to all the team's equipment, the shared IGH facilities, and the Biocampus platforms. Targeting meiotic DNA breaks to the right place at the right time Meiosis is the
-
behaviour using computational approaches such as Bayesian program synthesis and inverse reinforcement learning. Investigate the diversity of motor commands that could implement observed behaviours and explore
-
science campus. The team is composed of approximately ten members (http://ibv.unice.fr/research-team/besse/ ). Targeting of specific sets of RNA molecules to various subcellular localization has recently
-
Research Institute for Environmental and Occupational Health (IRSET - UMR_S INSERM 1085) | Rennes, Bretagne | France | 8 days ago
particles - in promoting inflammation and fibrosis, and work to identify specific biomarkers of exposure and associated risks in human and mouse models. Develop and evaluate therapeutic strategies to target
-
genes, thereby increasing their prevalence within a population. This approach can be used to disseminate a genetic modification through a target species, with the potential to control or eliminate
-
particles - in promoting inflammation and fibrosis, and work to identify specific biomarkers of exposure and associated risks in human and mouse models. Develop and evaluate therapeutic strategies to target